Go Pro
→ ALT SL: New Patent Reveals Elon Musk’s Next Breakthrough: M.A.G.I. (From Brownstone Research) (Ad)tc pixel
LON:GENI

GENinCode Final Earnings Report

GENinCode logo
GBX 0.83 -0.02 (-2.00%)
As of 10:32 AM Eastern
ProfileEarnings History

GENinCode EPS Results

Actual EPS
-GBX 2.53
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

GENinCode Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

GENinCode Announcement Details

Quarter
Final
Date
6/4/2025
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

GENinCode Earnings Headlines

GENinCode PLC
July 30, 2026  |  marketwatch.comhttps://www.marketwatch.com/investing/Stock/GENI?countryCode=UK
GENinCode Shareholders Approve All Resolutions at Annual General Meeting
July 1, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/genincode-shareholders-approve-all-resolutions-at-annual-general-meeting?utm_source=marketbeat.com&utm_medium=referral
This under $7 stock could be.
Just one mile from SpaceX's launchpad sits a small company doing something SpaceX can't - and it still trades under $7. Robert Kiyosaki calls it the 'Shadow SpaceX.' His go-to financial analyst found it before institutions moved in. That window may not stay open long.tc pixel
August 6 at 1:00 AM  |  Freedom Financial (Ad)
AIM Market Roundup: Marechale Capital, Genincode, Boohoo
June 5, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/aim-market-roundup-marechale-capital-153929945.html
GENinCode slumps after it reprices options
May 7, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/genincode-slumps-reprices-options-101000125.html
AIM Market Roundup: Phoenix Copper, Pipehawk, Genincode
February 25, 2026  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/aim-market-roundup-phoenix-copper-170020859.html
See More GENinCode Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GENinCode? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GENinCode and other key companies, straight to your email.

About GENinCode

GENinCode (LON:GENI) is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide. GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U. GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.

View GENinCode Profile
Earnings Tools